Switch theme
Sign up to access all valuation multiples
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is primarily generated from its hospital business and its medical equipment, software, and related services segment.
2008
733
LTM Revenue n/a
LTM EBITDA n/a
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Concord Healthcare Group has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Concord Healthcare Group achieved revenue of $69.2M and an EBITDA of -$22.2M.
Concord Healthcare Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Concord Healthcare Group valuation multiples based on analyst estimates| FY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $60.5M | $60.7M | $69.2M | n/a | XXX |
| Gross Profit | -$6.1M | -$18.3M | -$8.4M | XXX | XXX |
| Gross Margin | -10% | -30% | -12% | XXX | XXX |
| EBITDA | -$36.9M | -$28.9M | -$22.2M | n/a | XXX |
| EBITDA Margin | -61% | -48% | -32% | NaN% | XXX |
| Net Profit | -$105M | -$69.6M | -$48.0M | XXX | XXX |
| Net Margin | -174% | -115% | -69% | XXX | XXX |
| Net Debt | $270M | $294M | $302M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Concord Healthcare Group's stock price is HKD 8 (or $1).
Concord Healthcare Group has current market cap of HKD 6.0B (or $775M), and EV of HKD 8.8B (or $1.1B).
See Concord Healthcare Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $775M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Concord Healthcare Group has market cap of $775M and EV of $1.1B.
Concord Healthcare Group's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Concord Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Concord Healthcare Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.1B | XXX | XXX | XXX |
| EV/Revenue | 16.3x | XXX | XXX | XXX |
| EV/EBITDA | -50.8x | XXX | XXX | XXX |
| P/E | -16.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 483.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpConcord Healthcare Group's NTM/LTM revenue growth is n/a
Concord Healthcare Group's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Concord Healthcare Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Concord Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Concord Healthcare Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -32% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -23% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 54% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Concord Healthcare Group acquired XXX companies to date.
Last acquisition by Concord Healthcare Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Concord Healthcare Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Concord Healthcare Group founded? | Concord Healthcare Group was founded in 2008. |
| Where is Concord Healthcare Group headquartered? | Concord Healthcare Group is headquartered in Hong Kong. |
| How many employees does Concord Healthcare Group have? | As of today, Concord Healthcare Group has 733 employees. |
| Is Concord Healthcare Group publicy listed? | Yes, Concord Healthcare Group is a public company listed on HKG. |
| What is the stock symbol of Concord Healthcare Group? | Concord Healthcare Group trades under 02453 ticker. |
| When did Concord Healthcare Group go public? | Concord Healthcare Group went public in 2024. |
| Who are competitors of Concord Healthcare Group? | Similar companies to Concord Healthcare Group include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Concord Healthcare Group? | Concord Healthcare Group's current market cap is $775M |
| What is the current revenue growth of Concord Healthcare Group? | Concord Healthcare Group revenue growth between 2023 and 2024 was 14%. |
| Is Concord Healthcare Group profitable? | Yes, Concord Healthcare Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
